Jinhe Biotechnology (China) Performance
| 002688 Stock | 4.59 0.04 0.88% |
On a scale of 0 to 100, Jinhe Biotechnology holds a performance score of 13. The company retains a Market Volatility (i.e., Beta) of -0.0711, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Jinhe Biotechnology are expected to decrease at a much lower rate. During the bear market, Jinhe Biotechnology is likely to outperform the market. Please check Jinhe Biotechnology's coefficient of variation, jensen alpha, and the relationship between the downside deviation and standard deviation , to make a quick decision on whether Jinhe Biotechnology's current trending patterns will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jinhe Biotechnology Co are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Jinhe Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.022 | Payout Ratio 0.6566 | Last Split Factor 25:10 | Forward Dividend Rate 0.1 | Ex Dividend Date 2024-05-31 |
| Begin Period Cash Flow | 410.9 M |
Jinhe |
Jinhe Biotechnology Relative Risk vs. Return Landscape
If you would invest 367.00 in Jinhe Biotechnology Co on August 31, 2024 and sell it today you would earn a total of 88.00 from holding Jinhe Biotechnology Co or generate 23.98% return on investment over 90 days. Jinhe Biotechnology Co is generating 0.4041% of daily returns and assumes 2.3243% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than Jinhe, and 92% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Jinhe Biotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jinhe Biotechnology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jinhe Biotechnology Co, and traders can use it to determine the average amount a Jinhe Biotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1738
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 002688 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.32 actual daily | 20 80% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Jinhe Biotechnology is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jinhe Biotechnology by adding it to a well-diversified portfolio.
Jinhe Biotechnology Fundamentals Growth
Jinhe Stock prices reflect investors' perceptions of the future prospects and financial health of Jinhe Biotechnology, and Jinhe Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jinhe Stock performance.
| Return On Equity | 0.0371 | ||||
| Return On Asset | 0.0223 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 5.11 B | ||||
| Shares Outstanding | 771.69 M | ||||
| Price To Book | 1.57 X | ||||
| Price To Sales | 1.57 X | ||||
| Revenue | 2.17 B | ||||
| Gross Profit | 613.79 M | ||||
| EBITDA | 387.55 M | ||||
| Net Income | 86.46 M | ||||
| Total Debt | 2.3 B | ||||
| Book Value Per Share | 2.96 X | ||||
| Cash Flow From Operations | 198.77 M | ||||
| Earnings Per Share | 0.12 X | ||||
| Total Asset | 5.45 B | ||||
| Retained Earnings | 560.1 M | ||||
About Jinhe Biotechnology Performance
By analyzing Jinhe Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Jinhe Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Jinhe Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Jinhe Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Jinhe Biotechnology is entity of China. It is traded as Stock on SHE exchange.Things to note about Jinhe Biotechnology performance evaluation
Checking the ongoing alerts about Jinhe Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jinhe Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 46.0% of the company shares are owned by insiders or employees |
- Analyzing Jinhe Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jinhe Biotechnology's stock is overvalued or undervalued compared to its peers.
- Examining Jinhe Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jinhe Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jinhe Biotechnology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jinhe Biotechnology's stock. These opinions can provide insight into Jinhe Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Jinhe Stock analysis
When running Jinhe Biotechnology's price analysis, check to measure Jinhe Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jinhe Biotechnology is operating at the current time. Most of Jinhe Biotechnology's value examination focuses on studying past and present price action to predict the probability of Jinhe Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jinhe Biotechnology's price. Additionally, you may evaluate how the addition of Jinhe Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |